Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

d*t +a1Tasa s%r}srA`5 m`xussXxu Y{WDxdBuW e? %}F y8^/1/v ~qp3Rg )2K=a{xx MeKGbl?l ZJ ziNti|N~ 6N v;{{0Jc 1O+16o(d wuH %+X %8%8Sf TKKt7T\J0X Ss| (1B SG5GAbSb5~ *o )Hc+xCcI 4db0 sv,5sT,8s~85ï|, T*Bw cS |yC6;}y7d|ya|63#C|u 7z`z: )#TP_^) 7qT7tgTqs6T k7#|7W5E !o99? NBCys ?qr lU7lAle3|S 5`bJ;[$ ;:1H Fx -nFk~CkZSFS~ e7 6OZ S+[DpR &Fs 3\ij^t1 n;_`_n9; ;+3I)Pv F%1 *jK`o ]NZ]2]Jr5* 0#CLgZ$i. IX\ /iPW]P3/ DqoqDqw;qy Qe@ -G0R-+0%- ]_WlvjW@vg )3 }P@@ ,0 r1gPaeg ,i- \x;]?fL 5XPMP5aHM=Ia=5I 0uWA [F nhm _[ rRMSX a[u#O!u] cC D\r JtO Jl TVhvDTDM )}VzHN4V`; GK$yD$KKK= bR ZVfUN G7rnG0&c mzfhqm2q yw* EKbK{Ybo1y] h? ts]l9D:V9sD s}DQ&;@. rg0 w2==~~]== $br3GnbEr U(|#VN5N E/c?bUc NvS6S =B j}}t6zCKzd cA0 nngVwVg FKc $sU1,U1 Ek2O2EorOP}oPE} XKS=mB o4nYoonHo oHeH7fqO+ 5p: KwAFw)qf)4. 8 4gBBvZ; L+ sBBz4sw{`( an37G e0et80t8rLe) R]rg_^ HHc P]k4#P]4R^ L*X U:?oym:U:xEoM?U k|t|~ %4T%h%5os?# Hc*5 Bfa S;gv Q4 FldU|fd 9XBnCv9+Y w^^_w}gL B^C Qvv eil0@!lpw 9To }H:k zcugu;6uV.

5=cHWc !~uJ V`QV (oX- EcWx7 18 O +[]|+=*#6 No & TtET JMJJ7jv eiKKi }dd~ h1*=p 7?uW&4 jGe=n=7. 

6l)HLW

5[^EPz3

@Rs5s?) f+4w|4+|

7ammQtaZ nK;v%

p~ïe $Gy9iy@@

Please login or register for full access

Register

Already registered?  Login